Psychiatry and Neurology, Neurology · Memphis, TN
NPI
1760459168
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
6325 Humphreys Blvd
Memphis, TN, 38120
Phone (901) 522-7700
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.7M
118,958 services
Medicare patients, 2024
619
Average age 72
Drug cost, 2024
$10.4M
3,701 prescriptions
Company payments, 2025
$21K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tulio Bertorini was code J0585 (injection, onabotulinumtoxina, 1 unit), 14,045 times for 24 patients. In total Tulio Bertorini billed 118,958 services in 95 codes, and Medicare paid $3.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 14,045 | 24 | $4.89 | $69K |
| J1576 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 10,820 | 16 | $53.69 | $581K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 9,270 | 14 | $35.91 | $333K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 5,250 | 18 | $8.69 | $46K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 3,000 | 14 | $0.23 | $694 |
| 99213 Office E&M - Established | Office | 577 | 372 | $59.86 | $35K |
| 96366 Intravenous Infusion, Hydration | Office | 504 | 22 | $14.74 | $7,429 |
| 99214 Office E&M - Established | Office | 396 | 260 | $86.12 | $34K |
| A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | Office | 310 | 13 | $1.18 | $366 |
| 96365 Intravenous Infusion, Hydration | Office | 285 | 30 | $43.92 | $13K |
| 95885 Electrical Nerve Conductivity | Office | 248 | 114 | $35.44 | $8,789 |
| 99212 Office E&M - Established | Office | 106 | 95 | $35.16 | $3,726 |
| 99204 Office E&M - New | Office | 92 | 92 | $112.66 | $10K |
| 96413 Chemotherapy Administration | Office | 90 | 17 | $91.03 | $8,193 |
| 95886 Electrical Nerve Conductivity | Office | 73 | 51 | $53.28 | $3,889 |
By year: 2022 $1.2M for 33,334 services; 2023 $2.4M for 54,180 services; 2024 $3.7M for 118,958 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82565 Clinical Chemistry | 13 | 13 | $5.02 | $65.26 |
Medicare prescription drug claims, 2024
In 2024, the drug Tulio Bertorini prescribed most often to Medicare patients was Gabapentin, with 352 prescriptions and refills. In total Tulio Bertorini wrote 3,701 Medicare prescriptions that cost $10.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 352 | 486 | 72 | $4,494 |
| Radicava Ors Edaravone | 243 | 243 | 32 | $3.4M |
| Prednisone Generic | 218 | 326 | 44 | $1,649 |
| Baclofen Generic | 208 | 348 | 41 | $4,791 |
| Pyridostigmine Bromide Generic | 179 | 296 | 46 | $15K |
| Riluzole Generic | 151 | 195 | 30 | $17K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 120 | 251 | 27 | $3,537 |
| Sodium Chloride 0.9 % Sodium Chloride | 115 | 116 | 20 | $1,323 |
| Azathioprine Generic | 109 | 208 | 28 | $7,102 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 88 | 100 | Under 11 | $468K |
| Tizanidine Hcl Generic | 77 | 133 | 23 | $1,381 |
| Duloxetine Hcl Generic | 72 | 122 | 23 | $1,432 |
| Pregabalin Generic | 70 | 102 | 20 | $1,933 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 69 | 69 | Under 11 | $753K |
| Donepezil Hcl Generic | 62 | 147 | 18 | $793 |
Brand drugs: 980 claims; generic drugs: 2,684 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tulio Bertorini $21K ($21K in general payments such as food, travel and fees) from 13 companies. The largest payer was Argenx US, Inc. with $8,619.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.